Key clinical point: Use of intrauterine contraceptive devices was safe and effective for patients aged 22 years and younger with physical, intellectual, and developmental disabilities.

Major finding: The IUD continuation rate was 95% after 1 year and 73% after 5 years.

Study details: The data come from a retrospective study of 159 patients aged 22 years and younger with disabilities who received 185 levonorgestrel IUDs.

Disclosures: The study was supported by a Bayer Healthcare Investigator-Initiated Research grant for women’s health to Dr. Schwartz and coauthor Lesley L. Breech, MD. The researchers had no other financial conflicts to disclose.